Blended nanoparticle system based on miscible structurally similar polymers: a safe, simple, targeted, and surprisingly high efficiency vehicle for cancer therapy
- PMID: 25800699
- DOI: 10.1002/adhm.201400751
Blended nanoparticle system based on miscible structurally similar polymers: a safe, simple, targeted, and surprisingly high efficiency vehicle for cancer therapy
Abstract
A novel blended nanoparticle (NP) system for the delivery of anticancer drugs and its surprisingly high efficacy for cancer chemotherapy by blending a targeting polymer folic acid-poly(ethylene glycol)-b-poly(lactide-co-glycolide) (FA-PEG-b-PLGA) and a miscible structurally similar polymer D-α-tocopheryl polyethylene glycol 1000 succinate-poly(lactide-co-glycolide) (TPGS-PLGA) is reported. This blended NP system can be achieved through a simple and effective nanoprecipitation technique, and possesses unique properties: i) improved long-term compatibility brought by PEG-based polymers; ii) reduced multidrug resistance mediated by P-glycoprotein (P-gp) in tumor cells and increased bioavailability of anticancer drugs by incorporation of TPGS; iii) the regulation of controlled release through polymer ratios and active targeting by FA. Both in vitro cell experiments and in vivo antitumor assays demonstrated the reported blended NP system can achieve the best therapeutic efficiency in an extremely safe, simple and highly efficient process for cancer therapy. Moreover, this NP system is highly efficient in forming NPs with multiple functions, without repeated chemical modification of polymers, which is sometimes complex, inefficient and high cost. Therefore, the development of this novel blended NP concept is extremely meaningful for the application of pharmaceutical nanotechnology in recent studies.
Keywords: blended nanoparticles; cancer therapy; miscible polymers; multifunctional vehicles; pharmaceutical nanotechnology.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Similar articles
-
Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.Biomaterials. 2009 Jul;30(19):3297-306. doi: 10.1016/j.biomaterials.2009.02.045. Epub 2009 Mar 19. Biomaterials. 2009. PMID: 19299012
-
Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy.Acta Biomater. 2013 Nov;9(11):8910-20. doi: 10.1016/j.actbio.2013.06.034. Epub 2013 Jun 28. Acta Biomater. 2013. PMID: 23816645
-
Addition of TPGS to folate-conjugated polymer micelles for selective tumor targeting.J Biomed Mater Res A. 2009 Nov;91(2):505-18. doi: 10.1002/jbm.a.32220. J Biomed Mater Res A. 2009. PMID: 18985763
-
Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):427-43. doi: 10.1016/j.ejpb.2013.07.002. Epub 2013 Jul 17. Eur J Pharm Biopharm. 2013. PMID: 23872180 Review.
-
Recent advances in TPGS-based nanoparticles of docetaxel for improved chemotherapy.Int J Pharm. 2017 Aug 30;529(1-2):506-522. doi: 10.1016/j.ijpharm.2017.07.018. Epub 2017 Jul 12. Int J Pharm. 2017. PMID: 28711640 Review.
Cited by
-
Controlled Drug Delivery by Polylactide Stereocomplex Micelle for Cervical Cancer Chemotherapy.Front Pharmacol. 2018 Aug 14;9:930. doi: 10.3389/fphar.2018.00930. eCollection 2018. Front Pharmacol. 2018. PMID: 30154721 Free PMC article.
-
Two-Dimensional Antimonene-Based Photonic Nanomedicine for Cancer Theranostics.Adv Mater. 2018 Sep;30(38):e1802061. doi: 10.1002/adma.201802061. Epub 2018 Jul 24. Adv Mater. 2018. PMID: 30043416 Free PMC article.
-
Dipeptide-modified nanoparticles to facilitate oral docetaxel delivery: new insights into PepT1-mediated targeting strategy.Drug Deliv. 2018 Nov;25(1):1403-1413. doi: 10.1080/10717544.2018.1480675. Drug Deliv. 2018. PMID: 29890854 Free PMC article.
-
Recent Advances in the Application of Vitamin E TPGS for Drug Delivery.Theranostics. 2018 Jan 1;8(2):464-485. doi: 10.7150/thno.22711. eCollection 2018. Theranostics. 2018. PMID: 29290821 Free PMC article. Review.
-
H2O2-Responsive Nanoparticle Based on the Supramolecular Self-Assemble of Cyclodextrin.Front Pharmacol. 2018 May 28;9:552. doi: 10.3389/fphar.2018.00552. eCollection 2018. Front Pharmacol. 2018. PMID: 29892222 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous